Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Future aspects on inflammatory bowel disease

G Järnerot1

  • 1Dept. of Medicine, Orebro Medical Center Hospital, Sweden.

Scandinavian Journal of Gastroenterology. Supplement
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Smoking habits in patients with ulcerative colitis: evaluation of retrospective questionnaires.

Inflammatory bowel diseases·2013
Same author

Serum Procollagen III Propeptide Is Not of Diagnostic Predictive Value in Collagenous Colitis.

Inflammatory bowel diseases·2013
Same author

Antineutrophil Cytoplasmic Antibodies in Inflammatory Bowel Disease and Collagenous Colitis: No Association with Lactoferrin, β-Glucuronidase, Myeloperoxidase, or Proteinase 3.

Inflammatory bowel diseases·2013
Same author

Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study.

Alimentary pharmacology & therapeutics·2010
Same author

Altered colonic glycoprotein expression in unaffected monozygotic twins of inflammatory bowel disease patients.

Gut·2006
Same author

CARD15/NOD2 polymorphisms do not explain concordance of Crohn's disease in Swedish monozygotic twins.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2005
Same journal

Abstract from the 41st Nordic Gastroenterology Congress, 8-11 June 2010, Copenhagen, Denmark.

Scandinavian journal of gastroenterology. Supplement·2010
Same journal

Abstracts from the XL Nordic Meeting of Gastroenterology, June 8-11, 2009, Stavanger, Norway.

Scandinavian journal of gastroenterology. Supplement·2009
Same journal

Abstracts of the 39th Nordic Meeting of Gastroenterology, 30th Nordic Meeting of Digestive Endoscopy, 18th Nordic Meeting of Gastrointestinal Motility, and the Annual Endoscopy/Gastroenterology Nurses'/Assistants' Meeting Post-graduate course, 4-6 June 2008, Helsinki, Finland.

Scandinavian journal of gastroenterology. Supplement·2008
Same journal

Abstracts from the XXXVIII Nordic Meeting of Gastroenterology, XXIX Nordic Meeting of Digestive Endoscopy, XVII Nordic Meeting of Gastrointestinal Motility, 6-9 June 2007, Reykjavik, Iceland.

Scandinavian journal of gastroenterology. Supplement·2007
Same journal

Abstracts of the XXXVII Nordic Meeting of Gastroenterology, 3-5 May 2006, Vasteras, Sweden.

Scandinavian journal of gastroenterology. Supplement·2006
Same journal

Novel approaches in the outpatient care of patients with chronic inflammatory bowel disease.

Scandinavian journal of gastroenterology. Supplement·2006
See all related articles

Inflammatory bowel diseases (IBD) result from complex interactions between genetics and environmental factors. Understanding these triggers, like diet and infections, may lead to more targeted immunotherapies for IBD treatment.

Area of Science:

  • Gastroenterology and Immunology

Background:

  • Inflammatory bowel diseases (IBD) are multifactorial, influenced by both genetic predisposition and environmental exposures.
  • Current research explores hypotheses including the 'sheltered child' phenomenon, infectious agents, dietary influences, and vascular factors.

Purpose of the Study:

  • To review and synthesize current knowledge on external and internal environmental factors contributing to IBD pathogenesis.
  • To explore how emerging insights into immunology and environmental interactions may shape future IBD treatment strategies.

Main Methods:

  • Literature review of external environmental factors (childhood, infections, diet, vascular).
  • Examination of internal environmental factors, focusing on genetics (HLA class II antigens, pANCA).
  • Analysis of how external factors modulate the gut microbiome and mucosal integrity.

Related Experiment Videos

Main Results:

  • External factors can alter the gut flora, impacting colonic mucin metabolism and mucosal vulnerability.
  • Genetic factors, particularly HLA class II antigens and pANCA, are significant in IBD.
  • The interplay between genetics and environment is crucial for IBD development.

Conclusions:

  • Increased understanding of IBD's multifactorial etiology, encompassing genetic and environmental influences, is vital.
  • Future IBD treatments are likely to become more targeted, leveraging immunological insights to address specific inflammatory pathways.